Regencell Bioscience Holdings L (RGC)
NCM · Healthcare · Drug Manufacturers - Specialty & Generic
$5.65
-5.36%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Exchange
NCM
Currency
USD
About Regencell Bioscience Holdings L
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Annual Financials
| Metric | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |
| Operating Income | -7.6M | -6.3M | -4.7M | |
| Net Income | -7.4M | -5.9M | -4.3M | |
| Diluted EPS | $-0.02 | $-0.01 | $-0.01 | $-0.01 |